Abstract: Microelectronic assemblies, related devices and methods, are disclosed herein. In some embodiments, a microelectronic component may include a substrate having a first face and an opposing second face, wherein the substrate includes a through-substrate via (TSV); a first mold material region at the first face, wherein the first mold material region includes a first through-mold via (TMV) conductively coupled to the TSV; and a second mold material region at the second face, wherein the second mold material region includes a second TMV conductively coupled to the TSV.

Abstract: The present invention relates to a specific radiation-curable coating composition for improving the surface adhesion of plastic parts and its uses as a primer coat, as a base coat or as a clear coat. The composition may be pigmented or unpigmented and may be cured by UV and/or EB. The invention also relates to cured coating resulting from this cure and to the coated plastic substrate with improved surface adhesion.

Abstract: A deployable device includes a plurality of stowing rollers that can each move in rotation about a first axis Zi, a plurality of tape-springs, each capable of passing from a wound configuration in one of the stowing rollers to a deployed configuration along a second axis Xi substantially perpendicular to the first axis Zi of the associated stowing roller and having a substantially concave face, the concave faces of the tape-springs facing one another, the tape-springs being at least partially superposed in pairs over a contact surface. The deployable device comprises a reversible adherent link on the contact surface between at least two of the tape-springs in the deployed configuration.

Abstract: Client computer based user interface (UI) wizards for ingesting media content and associated metadata into a remote content management system (CMS) are disclosed. One or more UI wizards gather the media content and metadata by using user friendly interfaces that prompt a user for information. The UI wizards are representation agnostic. The UI wizard(s) bundle the media content and metadata and initiates upload of the bundle to a server computer in an automatically persistent manner.

Abstract: The invention concerns an osteosynthesis screw (1) formed from a core (2) externally provided with a helical thread (3), said screw comprising a distal penetration portion and a proximal portion forming the head of the screw (6) and having a conical longitudinal section characterized in that the proximal portion comprises annular notches which are formed in the thickness of the core (2) and in the gaps between the threads of said proximal portion in such a way as to reduce the radial pressure during screwing.—Surgical device.

Abstract: A separation apparatus for separating a superposed substrate in which a processing target substrate and a supporting substrate are joined together with an adhesive, into the processing target substrate and the supporting substrate, includes: a first holding unit which holds the processing target substrate; a second holding unit which holds the supporting substrate; a moving mechanism which relatively moves the first holding unit or the second holding unit in a horizontal direction; a load measurement unit which measures a load acting on the processing target substrate and the supporting substrate when the processing target substrate and the supporting substrate are separated; and a control unit which controls the moving mechanism based on the load measured by the load measurement unit.

Abstract: A superposed wafer is separated to a processing target wafer and a supporting wafer while being heated. Then, an adhesive on a joint surface of the processing target wafer is removed by supplying an organic solvent onto the joint surface of the processing target wafer. Then, an oxide film formed on the predetermined pattern on the joint surface of the processing target wafer is removed by supplying acetic acid to the joint surface of the processing target wafer. Then, the joint surface of the processing target wafer is inspected. Then, based on an inspection result, the adhesive on the joint surface of the processing target wafer is removed and the oxide film formed on the predetermined pattern on the joint surface of the processing target wafer is removed.

Abstract: The present invention relates to compounds of formula (I): in which Y, Y1, R1, R2, R3 and R4 are defined in the Summary of the Invention; capable of inhibiting the tyrosine kinase enzymatic activity of the Abelson protein (ABL1), the Abelson-related protein (ABL2) and related chimeric proteins, in particular BCR-ABL1. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.

Abstract: A method includes: a first step of disposing the superposed substrate at a position where the superposed substrate is not in contact with a first holding unit and a second holding unit in a space between the first holding unit and the second holding unit, and supplying an inert gas into the space; a second step of thereafter relatively moving the first holding unit and the second holding unit in the vertical direction, and holding the processing target substrate by the first holding unit and holding the supporting substrate by the second holding unit; and a third step of thereafter relatively moving the first holding unit and the second holding unit in the horizontal direction while heating the processing target substrate held by the first holding unit and the supporting substrate held by the second holding unit, to separate the processing target substrate and the supporting substrate from each other.

Abstract: A peeling device for peeling off a substrate to be processed and a support substrate from an overlapped substrate, the overlapped substrate being formed by bonding the substrate to be processed and the support substrate by an adhesive, which includes: a first holding unit configured to heat the substrate to be processed and configured to hold the substrate to be processed; a second holding unit configured to heat the support substrate and configured to hold the support substrate; a moving mechanism configured to horizontally move at least one of the first holding unit and the second holding unit relative to each other; and an inert gas supply mechanism configured to supply an inert gas onto a bonding surface of the substrate to be processed or a bonding surface of the support substrate.

Abstract: The present invention relates to compounds of formula (I): in which Y, Y1, R1, R2, R3 and R4 are defined in the Summary of the Invention; capable of inhibiting the tyrosine kinase enzymatic activity of the Abelson protein (ABL1), the Abelson-related protein (ABL2) and related chimeric proteins, in particular BCR-ABL1. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.

Abstract: A separation apparatus for separating a superposed substrate in which a processing target substrate and a supporting substrate are joined together with an adhesive, into the processing target substrate and the supporting substrate includes: a first holding unit that includes a heating mechanism heating the processing target substrate and holds the processing target substrate; a second holding unit that includes a heating mechanism heating the supporting substrate and holds the supporting substrate; a moving mechanism that relatively moves at least the first holding unit or the second holding unit in a horizontal direction; and a porous part that is annularly provided along an outer peripheral portion of the first holding unit and formed with a plurality of pores, and supplies an inert gas to the outer peripheral portion of the first holding unit holding the processing target substrate.

Abstract: Disclosed is a substrate conveyance apparatus capable of suppressing a substrate from being damaged. The substrate conveyance apparatus includes a plurality of nozzles, and a main body unit. The plurality of nozzles are configured to jet a gas toward a surface of a substrate to hold the substrate in a non-contact manner. The main body unit is provided with the plurality of nozzles. At least surfaces of the plurality of nozzles are formed of a resin.

Abstract: A provision system of surgical implants and associated surgical instruments. The invention concerns a provision system (1) of surgical implants intended to be attached on bone bodies of a patient, for example, his forearm, and surgical instruments intended for the implementation of these implants comprising such surgical implants and instruments in packaged form, said system (1) being characterized in that it forms a distribution unit (8) comprising: a plurality of unitary implant holders (9, 10, 11, 12), each containing one single surgical implant, each of said unitary holders (9, 10, 11, 12) containing an implant of different configuration, one single holder (20) of surgical instruments, containing said instruments, which are able to allow the implementation of any one of said surgical implants contained in said plurality of unitary implant holders (9, 10, 11, 12). The provision systems of implants and osteosynthesis surgical instruments.

Abstract: The invention relates to a shoe (1) for helping to position and fix a surgical implant which is intended to be attached to osseous bodies of a patient, for example those of the forearm, said shoe (1) having a main body (24) and being characterized in that said main body (24) has: at least one radiolucent zone (25) and at least one radiopaque zone (26), and means (27) for positioning said shoe (1) with respect to the surgical implant in a predetermined relative position, so as to allow monitoring of the positioning of said implant with respect to said osseous bodies of the patient. Devices for helping to fit surgical osteosynthesis implants in place.

Abstract: The present invention relates to compounds of formula I: in which Y, Y1, Y4, Y5, Y6, R1, R2, R3 and R4 are defined in the Summary of the Invention; capable of inhibiting the activity of BCR-ABL1 and mutants thereof. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.

Abstract: The present application relates to an embedded stress test circuitry for being formed on a substrate together with an operating circuit, both forming an electronic circuit. The embedded stress test circuitry comprises a test controller, a stress voltage regulator, which is controllably coupled to the test controller and arranged to generate a stress voltage signal in accordance with a stress voltage profile, a sensor, which is coupled to a component of the operating circuit and a storage, which is coupled to the test controller for storing the stress voltage profile.

Abstract: The present invention relates to compounds of formula (I): in which Y, Y1, R1, R2, R3 and R4 are defined in the Summary of the Invention; capable of inhibiting the tyrosine kinase enzymatic activity of the Abelson protein (ABL1), the Abelson-related protein (ABL2) and related chimeric proteins, in particular BCR-ABL1. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.

Abstract: The present invention relates to compounds of formula I: in which Y, Y1, Y4, Y5, Y6, R1, R2, R3 and R4 are defined in the Summary of the Invention; capable of inhibiting the activity of BCR-ABL1 and mutants thereof. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.

Abstract: The present invention relates to compounds of formula (I): in which Y, Y, R, R 2, R 3 and R 4 are defined in the Summary of the Invention; capable of inhibiting the tyrosine kinase enzymatic activity of the Abelson protein (ABL1), the Abelson-related protein (ABL2) and related chimeric proteins, in particular BCR-ABL1. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.